Increased intraocular pressure in mice treated with dexamethasone.

PURPOSE Glucocorticoids are potent modulators of the immune system and are useful in treating systemic and ocular diseases, but they can increase intraocular pressure (IOP) in susceptible persons. Steroid-induced ocular hypertension resembles several characteristics observed in primary open angle glaucoma (POAG). Elucidating genetic and environmental mechanisms impacting steroid-induced ocular hypertension may provide important insight into pathophysiological drivers of POAG. The purpose of this study was to create a mouse model of steroid-induced ocular hypertension. METHODS Osmotic mini-pumps delivering dexamethasone or PBS were implanted into C57BL/6J-Tyr(c-Brd) × 129S5/SvEvBrd (B6.129) mice. Repeated IOP measurements were obtained over a 4-week study using a tonometer before and after pump implantation. Body weights, complete blood counts (CBCs), and blood pressure were obtained to further characterize the model. Pharmacologic effects of timolol, latanoprost, and Y-39983 were studied in hypertensive mice. RESULTS Administration of dexamethasone to B6.129 hybrid mice resulted in significant increases in IOP in most animals compared with baseline or mice treated with PBS. No significant change in IOP was observed in PBS-treated mice. Interestingly, dexamethasone failed to increase IOP in a subset of mice, though steroid delivery was successful as measured using CBC analysis. Moreover, topical agents that lower IOP in normotensive mice also produced significant decreases in mice exhibiting elevated IOP in response to dexamethasone. CONCLUSIONS Systemic treatment with dexamethasone significantly increased IOP in most genetically heterogeneous mice used in this study. This mouse model should facilitate studies aimed at understanding mechanisms affecting steroid-induced ocular hypertension in humans.

[1]  V. Sheffield,et al.  Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. , 2001, Investigative ophthalmology & visual science.

[2]  A. Clark,et al.  Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. , 1995, Investigative ophthalmology & visual science.

[3]  J. Whitworth,et al.  CORTISOL AND HYPERTENSION , 1998, Clinical and experimental pharmacology & physiology. Supplement.

[4]  B. Becker,et al.  INTRAOCULAR PRESSURE RESPONSE TO TOPICAL CORTICOSTEROIDS. , 1965, Investigative ophthalmology.

[5]  A. Clark,et al.  Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. , 1994, Investigative ophthalmology & visual science.

[6]  P. Kaufman,et al.  β1 and β3 Integrins Cooperate to Induce Syndecan-4-Containing Cross-linked Actin Networks in Human Trabecular Meshwork Cells , 2006 .

[7]  B. Becker,et al.  CORTICOSTEROIDS AND INTRAOCULAR PRESSURE. , 1963, Archives of ophthalmology.

[8]  G. Lembo,et al.  Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  L. Bito,et al.  Steroid glaucoma: corticosteroid-induced ocular hypertension in cats. , 1992, Experimental eye research.

[10]  M. F. Armaly.  STATISTICAL ATTRIBUTES OF THE STEROID HYPERTENSIVE RESPONSE IN THE CLINICALLY NORMAL EYE. I. THE DEMONSTRATION OF THREE LEVELS OF RESPONSE. , 1965, Investigative ophthalmology.

[11]  J. Wilensky,et al.  The reproducibility of the intraocular pressure response to dexamethasone. , 1975, American journal of ophthalmology.

[12]  A. Flahault,et al.  Corticosteroid‐induced clinical adverse events: frequency, risk factors and patient’s opinion , 2007, The British journal of dermatology.

[13]  T. Davies.,et al.  Tonographic survey of the close relatives of patients with chronic simple glaucoma. , 1968, The British journal of ophthalmology.

[14]  Takeshi Ishibashi,et al.  Cdna Microarray Analysis of Gene Expression Changes Induced by Dexamethasone in Cultured Human Trabecular Meshwork Cells Materials and Methods Cell Culture , 2022 .

[15]  S. Sawaguchi,et al.  Myocilin Gene Expression in the Trabecular Meshwork of Rats in a Steroid-Induced Ocular Hypertension Model , 2005, Ophthalmic Research.

[16]  O. Lorenzetti.  Effects of corticosteroids on ocular dynamics in rabbits. , 1970, The Journal of pharmacology and experimental therapeutics.

[17]  Junhui Zhang,et al.  A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension. , 2008, Journal of the American Society of Nephrology : JASN.

[18]  A. Clark,et al.  The role of steroids in outflow resistance. , 2009, Experimental eye research.

[19]  A. Clark,et al.  The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. , 1992, Investigative ophthalmology & visual science.

[20]  D. Broadway,et al.  Corticosteroid-induced glaucoma: a review of the literature , 2006, Eye.

[21]  J. Whitworth,et al.  Glucocorticoids and the kidney , 2003, Nephrology.

[22]  J. T. Schwartz,et al.  Twin study on ocular pressure following topically applied dexamethasone. II. Inheritance of variation in pressure response. , 1973, A M A Archives of Ophthalmology.

[23]  V. Sheffield,et al.  Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. , 2001, Investigative ophthalmology & visual science.

[24]  A. Clark,et al.  Inhibition of dexamethasone-induced cytoskeletal changes in cultured human trabecular meshwork cells by tetrahydrocortisol. , 1996, Investigative ophthalmology & visual science.

[25]  C. R. Ethier,et al.  Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. , 2005, Cell motility and the cytoskeleton.

[26]  S. Anderson,et al.  Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions , 2009, PloS one.

[27]  Doyne Lecture.  New paradigms in the mechanisms and management of glaucoma , 2005 .

[28]  B. Becker,et al.  TOPICAL CORTICOSTEROIDS AND HEREDITY IN PRIMARY OPEN-ANGLE GLAUCOMA. , 1964, American journal of ophthalmology.

[29]  J. Yanni,et al.  Pharmacological validation of a feline model of steroid-induced ocular hypertension. , 1999, Archives of ophthalmology.

[30]  B. Becker,et al.  Steroid-induced elevation of intraocular pressure. , 1963, Archives of ophthalmology.

[31]  P. Knepper,et al.  Intraocular pressure and glycosaminoglycan distribution in the rabbit eye: effect of age and dexamethasone. , 1978, Experimental eye research.

[32]  L. Desantis,et al.  Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. , 1994, Current eye research.

[33]  Peter Vogel,et al.  Wnk1 kinase deficiency lowers blood pressure in mice: A gene-trap screen to identify potential targets for therapeutic intervention , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  I. Grierson,et al.  Cross-linked actin networks (CLANs) in the trabecular meshwork of the normal and glaucomatous human eye in situ. , 2009, Investigative ophthalmology & visual science.

[35]  J. Danias,et al.  Steroid-induced ocular hypertension in normal sheep. , 2009, Investigative ophthalmology & visual science.

[36]  J. Danias,et al.  Steroid-induced ocular hypertension in normal cattle. , 2004, Archives of ophthalmology.